
Joseph Califano
Director, Hanna and Mark Gleiberman Head and Neck Cancer Center · University of California (San Diego) Medical Center
Credentials: · · · ·
History
PresentHanna and Mark Gleiberman Head and Neck Cancer Center · University of California (San Diego) Medical Center

- 1989–1993
Research
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1
Science · 2011 · 1,418 citations
Genetic progression model for head and neck cancer: implications for field cancerization
Cancer Research · 1996 · First of 11 authors · 1,090 citations
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
The Journal of Clinical Endocrinology & Metabolism · 2005 · 808 citations
- DS
105 papers

90 papers · 1 as a resident

71 papers

59 papers · 24 as a resident

35 papers · 27 as a resident

22 papers

22 papers

20 papers · 19 as a resident
Grants
- 2026–2031
National Cancer Institute · R01
PI · $715.7K · Providence Health & Services - Oregon
- 2025–2030
National Cancer Institute · R01
Contact PI · $1.4M · University of California, San Diego
- 2024–2029
Imaging Tumor-Associated Macrophages in Head and Neck Squamous Cell Carcinoma Using Fluorine-19 MRI
National Cancer Institute · R01
PI · $2M · University of California, San Diego
- 2023–2028
Optimizing Immunoradiotherapy for HNSCC
National Cancer Institute · R01
Contact PI · $2.7M · University of California, San Diego
Clinical trials
- 2020–2024
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Principal investigator · Completed · Phase 2
University of California, San Diego
- 2012–2015
Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients
Principal investigator · Terminated · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2007–2012
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2017–2022

